Diabetes mellitus is known to be associated with neurological complications in both the peripheral and the central nervous system. Manifestations of cerebral disorders in diabetic patients include alterations in neurotransmission, electrophysiological abnormalities, structural changes and cognitive deficits [1±4]. In animal models of diabetic pathology, such as the streptozotocin-diabetic rat, spatial learning impairments have been reported [5] . This cognitive deficit is associated with changes in hippocampal synaptic plasticity, including an impaired expression of long term potentiation (LTP) [5, 6] and enhanced expres- Diabetologia (1999) Abstract Aims/hypothesis. Moderate disturbances of learning and memory were recognized as a complication of diabetes mellitus in patients. The streptozotocin-diabetic rat, an animal model of insulin-dependent diabetes, shows impairments in spatial memory and in long-term potentiation expression. We have studied the effect of experimental diabetes on expression of post-synaptic glutamate N-Methyl-D-Aspartate ionotropic receptors and of other key proteins regulating synaptic transmission at the post-synaptic compartment.
sion of long-term depression (LTD) [7] . LTP and LTD are activity-dependent modifications of synaptic strength, which have attracted considerable attention in the search for the cellular mechanisms of learning and memory. LTP can be defined as a prolongued enhancement of the efficacy of excitatory synaptic transmission, whereas LTD can be defined as a prolongued reduction of the efficacy of excitatory synaptic transmission. Both LTP and LTD can be elicited in the brain in vivo and in vitro by stimulation of excitatory afferents [8, 9] . The molecular mechanisms underlying these changes in hippocampal plasticity are largely unknown. It is tempting to suggest, however, that factors that would affect the frequency-dependent rise in postsynaptic calcium concentration, such as alterations in ionotropic glutamate receptors or in the activity of phosphatases and kinases or both, are involved. It is generally accepted that LTP and LTD induction involves a differential rise in Ca 2+ concentration in the postsynaptic cell. The different calcium concentrations achieved by the different stimulation paradigms necessary to induce LTP and LTD are thought to change the degree of protein phosphorylation, through activation of either kinases (LTP) or phosphatases (LTD) or both [10±12] .
It is known that excitatory transmission in the brain is largely mediated by glutamate acting through different classes of receptors: ionotropic [1-a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and N-Methyl-D-Aspartate (NMDA)] and metabotropic (mGluRs). In excitatory synapses the frequency-dependent Ca 2+ influx is mediated largely by NMDA receptors. NMDA receptors are heteromeric glutamate-gated ion channels in the central nervous system (CNS) [13, 14] and are formed by monomers of two families of homologous subunits NR1 and NR2A-D that are differentially expressed in the CNS [15] . These receptors are highly enriched in post-synaptic densities (PSD) [16, 17] . PSD is a fibrous specialization of cytoskeletal elements adhering to the postsynaptic membrane and serving as scaffold for neurotransmitter receptors and accessory proteins. In isolated PSD, AMPA and NMDA receptors are highly enriched [16, 18, 19] and so are different classes of kinases such as the non-receptor tyrosine kinase src and the multifunctional Ca 2+ /CaM dependent protein kinase II (CaMKII), the latter comprising up to 30 % of the total PSD proteins [16, 19] . Specific substrates for CaMKII in PSD are AMPA receptors, whose phosphorylation is increased during LTP [20] , and NMDA receptor subunits [21, 25] .
Therefore, we studied the effects of experimental diabetes on the postsynaptic molecular machinery involved in hippocampal synaptic plasticity. We focused on the postsynaptic compartment since paired pulse facilitation, an electrophysiological tool for detecting changes in presynaptic processes involved in neurotransmitter release [22] , was unaffected in diabetic rats [5] . In particular, we have addressed the questions whether the disturbances in hippocampal synaptic plasticity in diabetic rats are associated with i) a changed composition of NMDA receptors, thus implying changed expression of specific subunits and ii) changes in and phosphorylation of specific subunits of NMDA receptor, as the result of changes in CaM-KII activity.
Materials and methods
Experimental design. Male Wistar rats (starting weight ± 300 g, UWU-CPD, Harlan, Utrecht, The Netherlands) were used. Diabetes mellitus was induced by a single intravenous injection of streptozotocin (STZ) (Serve Feinbiochemia GMBH, Heidelberg, Germany) at a dose of 40 mg/kg body weight dissolved in saline.
The experimental groups consisted of: 1) rats with a diabetic duration of 4 months (n = 20); 2) age-matched nondiabetic control rats (n = 28); 3) rats with a diabetic duration of 7 months (n = 7); 4) rats with a diabetic duration of 4 months followed by 3 months of insulin intervention treatment (n = 6); 5) age-matched control rats (n = 7).
Insulin was given through subcutaneous sustained release insulin implants at a dose of 2±4 IU per day (Linplant, Mollegaard, Ejby, Denmark). Glucose concentrations were measured every 2 weeks in the insulin-treated animals in blood Antibodies and probes. Antibodies against aCaMKII were purchased from Boehringer (Mannheim, Germany) and antibodies against NR1, NR2A, NR2B, and GluR2/3 from Chemicon (Tamecula Calif., USA). PSD95 was from Affinity Bioreagents (Golden, USA).
The probes for NR1, NR2A were synthesized by Primm Laboratories (Milan, Italy) and the probe for NR2B by MWG Biotech (Ebersberg, Germany) according to the sequence reported previously [15] .
Post-synaptic density preparation. To isolate PSD from rat cortex and hippocampus, a modification of the method by Carlin et al. [23] was used. Briefly, animals were killed by decapitation and cerebral cortex (6 rats/preparation) and hippocampus (6±10 animals/preparation) were rapidly dissected and pooled. Since it has been suggested that CaMKII could translocate to the PSD post-mortem [24] , not more than 2 min elapsed between decapitation and tissue processing; if more, the tissue specimen were discarded. Homogenization was carried out by 10 strokes in a Teflon-Glass homogenizer (700 rev/min) in 4 ml/g of cold sucrose 0.32 mol/l containing HEPES 1 mmol/l, MgCl 2 1 mmol/l, NaHCO 3 1 mmol/l, pH 7.4 in presence of a complete set of proteases inhibitors (Complete, Boehringer Mannheim Gmbh, Mannheim, Germany). The homogenized tissue was centrifuged at 1000´g for 10 min. The resulting supernatant was centrifuged at 3000´g for 15 min to obtain a fraction of mitochondria and synaptosomes. The pellet was resuspended in a 2.4 ml/g of 0.32 mol/l sucrose, overlaid on sucrose gradient (0.85±1.0±1.2 mol/l) and centrifuged at 82 500´g for 2 h. The fraction between 1.0 and 1.2 mol/l sucrose was removed and diluted with an equal volume of 1 % Triton X-100 in sucrose 0.32 mol/l in HEPES 1 mmol/l and stirred at 4°C for 15 min. This solution was spun down at 82 500´g for 30 min. The pellet was resuspended, layered on sucrose gradients (1.0±1.5±2.1 mol/l) and centrifuged at 100 000´g at 4°C for 2 h. The fraction between 1.5 and 2.1 mol/l was removed and diluted with an equal volume of 1 % Triton X-100 and KCl 150 mmol/l. PSD were finally collected by centrifugation at 100 000´g at 4°C for 30 min and stored at ±80°C.
Endogenous phosphorylation and immunoprecipitation. CaM-KII-dependent endogenous phosphorylation of PSD proteins and immunoprecipitation assays were done as described previously [25] . Briefly, one mg of purified PSD either from cortex or from hippocampus was incubated in a buffer solution containing: HEPES 20 mmol/l, pH 7.4, MgCl 2 10 mmol/l, Okadaic acid 10 ±5 mol/l (Sigma, St. Louis, Mo., USA), phenyl-methylsulphonyl fluoride (PMSF) 100 mmol/l, DTT 20 mmol/l with 100 mmol/l of g-32 P-ATP (1 mCi/tube; 5000 Ci/mmol; Amersham International plc, Little Chalfont, UK) in the presence of either 1 mmol/l CaCl 2 and 40 mg/ml calmodulin or of 1 mmol/l EGTA. Reactions were carried out at 37°C for 5 min and were stopped either by the addition of the electrophoresis sample buffer (SDS 2 %, glycerol 10 %, b-mercaptoethanol 5 %, 62.5 mmol/l Tris-HCl pH 6.8) or by immersing in liquid nitrogen. Proteins were separated by SDS-PAGE (Running gel: acr. 6 %) and phosphoproteins shown by autoradiography. Quantification was done by computerized assisted image analysis (software: NIH-Image, Bethesda, Md., USA).
For immunoprecipitation, post-synaptic density proteins were incubated in buffer B containing: NaCl 200 mmol/l, EDTA 10 mmol/l, Na 2 HPO 4 10 mmol/l, NP-40 0.5 %, SDS 0.1 % in a final volume of 400 ml with antibodies against NR2A/ B or CaMKII as indicated in the text (dilution 1:100) overnight at 4°C. Protein A-agarose beads (5 mg/tube) or staphylococcus aureus cowan I cells (0.5 %) washed in the same buffer, were added and incubation was continued for 2 h. The beads were collected by centrifugation and washed three times with buffer A. Sample buffer for SDS-PAGE was added and the mixture was boiled for 3 min. Beads were pelletted by centrifugation and a volume of supernatants was applied to SDS-PAGE 6 %.
CaMKII assay. CaMKII activity was measured according to Fukunaga et al. [26] . Briefly, one mg of PSD proteins prepared from cortex and hippocampus were incubated in a medium containing: HEPES 50 mmol/l, pH 7.4, Mg acetate 10 mmol/l, 100 mmol/l g-32 P-ATP, syntide-2 40 mmol/l, CaCl 2 1 mmol/l and calmodulin 40 mg/ml in a final volume of 25 ml. Reactions were carried out at 37°C for 5 min and stopped by spotting on phosphocellulose paper.
In situ hybridization. In situ hybridization of NR1, NR2A and NR2B mRNA was carried out as described in another report [27] . Adult male Wistar rats were killed and and their brain removed rapidly and stored at ±80°C, until processed. 12 mm thick sections from control animals and diabetic rats were thawmounted onto gelatin-coated microscope slides and subsequently fixed in 4 % paraformaldehyde in phosphate buffered saline (PBS). Prehybridization and hybridization reactions were done as described previously [28, 29] with oligonucleotide probes radiolabelled at the 3 ¢-end with a-[
35 S]dATP (Dupont-NEN, Boston, Mass., USA; 1400 Ci/mmol) using terminal deoxynucleotidyl transferase. Quantification was done by computerized assisted image analysis (software: NIH-Image).
Results
NR1, NR2A, NR2B gene expression. In situ hybridization histochemistry was used to investigate the expression of NMDA receptor subunits in the brains of diabetic rats. Figure 1 shows a representative autoradiogramme of NR1, NR2A, NR2B subunit expression in control (C) and diabetic rats (D). In control rats transcripts of NR1, NR2A and NR2B subunits show the same anatomical localization, as reported previously [15] for adult brain. Quantitative analysis done on coronal slices from three different animals per group, at two different levels [30] , showed that in control brains, the level of transcripts for NR2B was much lower than for NR2A, as expected in adult rats. The diabetic condition did not change either the anatomical localization or the level of NR1 and NR2 A subunits transcript. The mRNA levels of NR2B in diabetic rats are, however, reduced when compared with control rats. Indeed, semiquantitative analysis of transcripts showed a decrease of 37.4 ± 5.8 % in the NR2B mRNA levels in the hippocampus of diabetic rats when compared with control rats (p < 0.01 vs diabetic brains vs control brains).
NR1, NR2A and 2B protein level and phosphorylation in post-synaptic densities of control and diabetic rats. To evaluate protein concentrations of glutamate receptors and signalling proteins, such as CaMKII, Western blot analyses were done on PSD obtained from the cortex and hippocampus of control and diabetic rats. Figure 2 shows that the immunostaining of NR1 and NR2A is the same in hippocampal PSD of both control and diabetic rats. In contrast, the Western blot analysis for NR2B showed a reduction of about 40 % in hippocampal PSD of diabetic rats compared with control rats, in agreement with in situ hybridization studies. In addition, the concentration of proteins highly enriched in PSD such as aCaMKII and PSD-95, a marker for PSD [19] , is the same in control and diabetic rats, thus suggesting that the composition of postsynaptic densities is the same in control and diabetic rats. Similar results were obtained in cerebral cortex PSD (data not shown).
We then tested the possible effect of diabetes on the phosphorylation of the NMDA receptor subunits. It has been shown that in adult brain PSD, the NMDA receptor subunits are substrates for CaMKII [21, 25] . PSD purified from cortex and hippocampus of both control and diabetic rats reacted under conditions known to obtain Ca 2+ /CaM dependent phosphorylation and proteins were resolved in SDS-PAGE. Figure 3 shows a representative autoradiogramme of endogenous CaMKII-dependent phosphorylation of PSD proteins obtained from hippocampus of control and diabetic rats. There was no detectable difference in basal phosphorylation of PSD proteins between control and diabetic rats. The addition of Ca 2+ /CaM stimulated 32 P-phosphate incorporation into many protein bands in both experimental groups, when compared with magnesium-dependent basal (calcium-independent) phosphorylation ( Fig. 3) , albeit to a lesser degree in the diabetic condition. Similar results were obtained using PSD purifed from cerebral cortex.
When phosphorylated PSD proteins were quantitatively immunoprecipitated using anti-NR2A/B polyclonal antibody, a phosphorylated band at 170 kDa is evident, corresponding to receptor subunits NR2A/B (Fig. 4 ; immunoprecipitation from hippocampal PSD). In diabetic rats the Ca 2+ /CaM stimulated phosphorylation of the immunoprecipitated NR2A/B is decreased when compared with control rats in agreement with results shown in Fig. 3 . In the same autoradiogramme a phosphorylated band at 50 kDa is also present, consistent with previous findings showing that autophosphorylated a-subunit of CaM-KII co-precipitates with NR2A/B [25] . In addition, when phosphorylated PSD from the hippocampus of control and diabetic rats are immunoprecipitated with polyclonal antibodies recognizing specifically NR2A and NR2B, a decrease in the phosphorylation of both NMDA receptor subunits was observed (data not shown).
The observed net decrease in the 32 P-incorporation in NR2A/B subunits in diabetic rats can be due not only to the decrease in the substrate concentration (NR2B), but also either to a decrease in the activity of the kinase or to an increased in vivo phosphorylation preceding the post-hoc assay. To clarify this issue, CaMKII-dependent phosphorylation of exogenously added synthetic peptide (syntide-2) was done (Fig. 5 ). In these experimental conditions Ca 2+ / CaM stimulated phosphorylation of syntide-2 was decreased in cortical and hippocampal PSD from diabetic rats compared with control rats. This decrease in Ca 2+ /CaM stimulated syntide-2 phosphorylation was quantitatively similar (about 60 % in the cortex and 30 % in the hippocampus) to that observed in the post-hoc phosphorylation assay for the endogenous substrates NR2A/B. Again no difference was observed in basal phosphorylation of the exogenous substrate syntide-2. These data suggest that the observed reduction in CaMKII-dependent phosphorylation is not only due to a lack of one of the endogenous substrates (NR2B), but is also related to a decreased activity, being an intrinsic property of the PSD-associated CaMKII in diabetic rats.
Effect of the insulin intervention treatment. It has been shown previously that a deficit in behavioural learning and hippocampal plasticity in STZ-diabetic rats can be fully prevented but only partially reversed by insulin treatment [31] .
The insulin treatment regimen effectively restored blood glucose and body weight towards control values (Table 1) .
In our study we tested whether, under the same conditions as before, the insulin treatment would affect the CaMKII activity in PSD. Figure 6A shows results of phosphorylation of syntide-2 using hippocampal PSD obtained from age-matched control rats, 7-months-old diabetic, and 7-months-old diabetic rats treated with insulin for the last 3 months. As in animals with a duration of diabetes of 4 months (Fig. 5) , CaMKII activity is reduced by about 40 % in hippocampal PSD of 7 months diabetic rats compared with control rats. Insulin treatment induced a moderate increase in CaMKII activity but failed to restore it to control level. Note that this effect is paralleled by a modest increase in NR2B protein concentrations in PSD as shown by Western blot analysis (Fig. 6B) . No changes in immunostaining of other PSD proteins (Fig. 1) were observed (data not shown).
Discussion
In this study we have evaluated the effects of a chronic diabetic status on gene expression and protein concentrations of NMDA receptor subunits in the brain and examined the phosphorylation of specific NMDA receptor subunits mediated by CaMKII both in a consolidated status diabeticus and after a prolongued insulin intervention treatment. Our main finding is that NMDA receptor subunit NR2B expression is reduced. Furthermore, the CaMKII-dependent ser/thr phosphorylation of both NR2A and NR2B subunits of the NMDA receptor is changed in PSD of specific brain areas of diabetic rats. In addition, the activity of CaMKII, which is physically associated with NR2 subunits of NMDA receptor in PSD [25] and mediates their phosphorylation, is reduced in diabetic rats. A 3 months insulin intervention treatment only partially restores these variables.
It should be noted that the functional and molecular changes observed in the STZ-diabetic rat model are considered to be the consequences of hyperglycaemia and insulin deficiency, rather than a consequence of direct STZ toxicity on the brain. This is strongly supported by the observation that in this model functional changes can be fully prevented by insulin treatment immediately following STZ-injection [31] . Moreover, since STZ transport and cytotoxicity is dependent on expression of the GLUT2 glucose transporter [32] and neither the blood brain barrier nor cerebral neurons express the GLUT2 transporters [33] , direct toxic effects of STZ on the brain can be ruled out.
The question of how chronic diabetic pathology could change the expression of a specific NMDA receptor subunit is currently under investigation. Recently, it has been shown that transient ischaemia [34] selectively influences the expression and protein concentration of NR2B, and that mRNA levels of different subunits of NMDA receptors change after 6-hydroxydopamine lesions [35] , chronic dopamine antagonists treatment [36] , oestrogen treatment [37] , epileptic seizures [38] . Although the mechanisms governing these changes in message levels remain largely unknown, recently the hypothesis that growth factors might influence these variables has been put forward. In particular nerve growth factor (NGF) might influence the activity of the promoter region of NR1 subunit gene, possibly through increasing the expression of the early-gene family of transcription factors, such as NGF-inducible factors (NGFIs) or early growth reaction factors (Egr) [39] . The possibility that growth factors other than NGF can influence the expression of NMDA receptor subunits is likely. Diabetes is known to affect a number of growth factors among which are NGF and IGF. It has been reported previously that in diabetic rats insulin growth factor-1 (IGF-1) and IGF-2 mRNA content is reduced in sciatic nerve and that circulating concentration of IGF-1 tend to be reduced in diabetic patients and in STZ-treated diabetic rats [40, 41] . In this respect, the possibility that IGF-1/IGF-2 might influence the activity of the promoter of different NR2 subunits is particularly intriguing. The observation that after a prolonged treatment of diabetic rats with insulin, the concentration of NR2B protein is partially restored might support such a hypothesis. This effect appears specific for NR2B subunits, since the expression of other NR subunits or other GluR receptors, such as GluR2/3 (data not shown) is not modified in diabetic rat brain. Concomitantly and irrespectively of the reduced NR2B concentration in PSD, the activity of CaM-KII-associated with PSD is decreased in diabetic rats when compared with control rats, as shown by CaM-KII assay done on exogenous substrate. This raises the possibility that other CaMKII substrates present in PSD could also show a reduced degree of phosphorylation (i. e. AMPA receptors) [20] . Why CaMKII activity is down-regulated in diabetic rats and whether this is due to disturbances in presynaptic function, such as neurotransmitter release, or solely to postsynaptic plasticity, is presently under investigation. An involvement of disturbance of presynaptic function is, however, unlikely, since PPF is unmodified in diabetic rats when compared with control rats.
These findings describing a malfunctioning of post-synaptic components define another tile of the complex pathogenesis of cerebral disorders associated with diabetic pathology. Diabetes is known to induce alterations of second messenger systems such as cAMP [42] and phosphoinositide [43] , as well as alterations of protein kinases other than CaMKII, such as PKC [44] . Moreover, diabetic pathology is known to produce a dysfunction in calcium homeostasis [45] . Indeed, our data suggest that a dysfunction in intracellular calcium regulation could occur at the postsynaptic side and it is reflected in a defective activation of CaMKII. Reduced CaMKII activity, in turn, could disturb the delicate balance between phosphatase and kinase activity at the postsynaptic side, thus hampering expression of LTP and favouring expression of LTD, as has been reported in STZ-diabetic rats [9] .
Are the changes in NR2B expression and CaMKII activity sufficient to explain changes in synaptic plasticity described previously in diabetic rats? It is known that an imbalance between the NR2B and NR2A subunit composition change the physiology of cells bearing NMDA receptor. Experiments done using recombinantly expressed NMDA receptors indicate that the subunit composition strongly affects the electrophysiological properties of NMDA receptor subtypes. In particular the NR2A-containing receptor channels differ from the other channel subtypes by considerable shorter offset decay time courses following brief application of L-glutamate [46] . The offset decay time course is thought to be crucial for the coincidence detection of pre-and post-synaptic activities; whether these kinetic characteristics can also represent a molecular rationale for a different vulnerability is still controversial. It may also be possible that chronic metabolic stress induces changes in the stoichiometric composition of the NMDA receptor complex, thus influencing the kinetic of excitatory transmission in these animals.
NMDA receptor channel opening and duration can be regulated by phosphorylation of specific subunits mediated by different kinases [47] . In particular NR1 subunits are phosphorylated by PKC [48, 49] whereas NR2B subunits may be phosphorylated both by CaMKII [21, 25] and by a tyrosine kinase [47, 50] . In both cases phosphorylation is of functional relevance. Here we show that CaMKII-dependent phosphorylation of NR2A and B subunits is markedly reduced in both cortex and hippocampus of diabetic rats. Therefore, both the decreased expression of NR2B subunit and the decreased CaMKII-dependent phosphorylation of NR2 subunits could be involved in the changed expression of LTP/LTD observed in diabetic rats. Electrophysiological studies, using intracellular recording techniques, are currently in use to examine the functional consequences of changes in the expression and phosphorylation of subunits.
In addition, insulin intervention treatment of diabetic rats for 3 months after the establishment of diabetes only partially restores CaMKII activity as well as NR2B levels. Recently it has been reported that insulin intervention treatment which is able to nearly normalize blood glucose concentrations, body weights and impaired nerve conduction velocities had only a limited effect on water maze performances in STZ treated rats and on LTP [7] . Our data at the molecular level showing only a moderate effect on CaMKII activity and NR2B levels are in line with this observation, emphasising the functional significance of the present finding.
In conclusion, CaMKII activity as well as NR2B levels, are affected in diabetic rats. Insulin treatment can restore both these parameters only partially. These changes may represent the molecular correlate of previously reported deficits in learning and hippocampal plasticity.
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